Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023...

ELEVAI Labs, Inc. Expands International Distribution into Europe...

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondri...

ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering...

ELEVAI Labs, Inc. Announces Pricing of $6,000,000 Initial Public Offering...

ELEVAI Labs Partners with Dmark Multisales Corporation as Exclusive Philippines Distributor...

ELEVAI Labs Announces New International Distributor Agreement with Central Circle Company in Kuwait...

ELEVAI LABS AMPLIFIES INTERNATIONAL REACH THROUGH VIET CAN TRADING AND SERVICE CO., LTD. WITH DISTRI...

ELEVAI Labs Announces Research Grant Award and Partnership to Better Characterize the ’Payload’ ...

ELEVAI BRINGS PARADIGM-SHIFTING PROCEDURE SKINCARE TO ASLMS Company Unveils Groundbreaking Approach ...

ELEVAI LABS EXPANDS INTERNATIONAL REACH WITH INDUSTRY LEADER EVOLVE MEDICAL INC. FOR CANADIAN DISTRI...

ELEVAI LABS EXPANDS BOARD OF DIRECTORS WITH THE APPOINTMENT OF GLOBAL AESTHETICS EXECUTIVE CRYSTAL M...

ELEVAI LABS RETURNS TO INDUSTRY-LEADING OCTANE AESTHETICS TECH FORUM “People’s Choice Award” W...